Cell and Tissue Engineering
Recent news:
Professor Michael Yartsev has been named to the John Simon Guggenheim Memorial Foundation’s 101st Class of Fellows for his trailblazing work in neuroscience and neuroengineering. One of the country’s most prestigious awards, fellowships are given to innovators in a wide range of disciplines with a monetary stipend allowing them to pursue independent work at the highest level under “the freest possible conditions.”
Recent research from Professor Derfogail Delcassian’s lab explores how the stiffness of swollen lymph nodes increases the strength, but decreases the precision, of cancer-killing immune cells.
Graduating senior Emma Berman lives at the intersection of engineering, medicine and community.
A research project on “the protein code of brain aging: from molecules to mechanisms,” by Professor Amy Herr has been selected for a Weill Neurohub Investigator Award. The Investigators program funds top faculty to form cross-campus, interdisciplinary teams to explore, create, and test bold new concepts and technologies.
An in-depth look at research by Professor Phil Messersmith, who draws on biology to develop cutting-edge materials for medicine. His lab creates adhesives and therapies designed to work with the human body, offering new ways to repair tissues, heal wounds and treat disease.
Professor Dan Fletcher has been elected to the National Academy of Medicine for his contributions to the mechanistic understanding of biological self-assembly and mechanotransduction, and his work developing mobile phone-based microscopy for remote diagnosis of infectious diseases. Election to the academy is considered one of the highest honors in the fields of health and medicine.
Researchers from Professor Michael Yartsev’s lab used wireless recording devices to track neural activity in Egyptian fruit bats, revealing new clues to how our long-term memories are formed.
Professor Phil Messersmith and colleagues have launched HypO2Regen Therapeutics, a startup developing novel, disease-modifying therapeutics for chronic intractable inflammatory diseases, including the first cell-free stem cell treatment that induces true regeneration of damaged tissue. Their first effort takes aim at periodontitis, which affects over 300 million people worldwide.
Michael Yartsev will receive the 2025 Richard Lounsbery Award from the National Academy of Sciences to recognize his extraordinary scientific achievement in understanding the neural basis of natural behaviors.